Deborah M. Autor sold $334k of AMRX
director at Amneal Pharmaceuticals, Inc.. 40,000 shares at an average of $8.35, traded Nov 21, 2024, filed Nov 25, 2024.
Score components
- +15RoleDirector
- +15Trade size$334k at market
- +10Share of holdings soldSold 43% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-24-049149, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | SOpen-market sale Class A Common Stock | -6,771 | $8.41 | $57k | 86,631 | Nov 25, 2024 |
| Nov 22, 2024 | SOpen-market sale Class A Common Stock | -33,229 | $8.34 | $277k | 53,402 | Nov 25, 2024 |
Related signals
Other insiders at Amneal Pharmaceuticals, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 49Moderate | Amneal Pharmaceuticals, Inc. | John Kiely director | $295k 32,000 shares | -12% | |
| 65Notable | Amneal Pharmaceuticals, Inc. | Nikita Shah Executive Vice President | $1.2M 120,832 shares | -45% | |
| 60Notable | Amneal Pharmaceuticals, Inc. | Andrew S Boyer Executive Vice President | $2.6M 279,244 shares | -65% | |
| 82Strong | Amneal Pharmaceuticals, Inc. | Tasos Konidaris Executive Vice President & CFO | $4.7M 499,730 shares | -80% | |
| 55Moderate | Amneal Pharmaceuticals, Inc. | Nikita Shah Executive Vice President | $666k 71,694 shares | -21% | |
| 49Moderate | Amneal Pharmaceuticals, Inc. | Andrew S Boyer Executive Vice President | $303k 33,436 shares | -12% | |
| 62Notable | Amneal Pharmaceuticals, Inc. | Jason B. Daly EVP, Chief Legal Officer | $199k 22,000 shares | -67% | |
| 52Moderate | Amneal Pharmaceuticals, Inc. | Nikita Shah Executive Vice President | $452k 50,000 shares | -13% | |
| 17Weak | Amneal Pharmaceuticals, Inc. | Gautam Patel director | $761k 94,906 shares | -6% | |
| 32Weak | AMRXsell Amneal Pharmaceuticals, Inc. | Gautam Patel director | $453k 56,426 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.